Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol., 18 October 2018
Sec. Parasite and Host
This article is part of the Research Topic Toxoplasma gondii Host Interactions: A Story of Immune Attack and Parasite Counterattack View all 19 articles

Toxoplasma Does Not Secrete the GRA16 and GRA24 Effectors Beyond the Parasitophorous Vacuole Membrane of Tissue Cysts

  • Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, Davis, CA, United States

After invasion, Toxoplasma resides in a parasitophorous vacuole (PV) that is surrounded by the PV membrane (PVM). Once inside the PV, tachyzoites secrete dense granule proteins (GRAs) of which some, such as GRA16 and GRA24, are transported beyond the PVM likely via a putative translocon. However, once tachyzoites convert into bradyzoites within cysts, it is not known if secreted GRAs can traffic beyond the cyst wall membrane. We used the tetracycline inducible system to drive expression of HA epitope tagged GRA16 and GRA24 after inducing stage conversion and show that these proteins are not secreted beyond the cyst wall membrane. This suggests that secretion of GRA beyond the PVM is not important for the tissue cyst stage of Toxoplasma.

Introduction

Toxoplasma gondii, which belongs to the phylum Apicomplexa, is an obligate intracellular parasite that can cause disease in immuno-compromised patients and fetuses (Montoya and Liesenfeld, 2004; Weiss and Dubey, 2009). It is the causative agent of toxoplasmosis, the 2nd most common cause of food-borne illness in the USA (Jones and Dubey, 2012). Infectious tissue cysts are present in brain and muscles of many warm-blooded chronically infected hosts (Kim and Weiss, 2004). Infected cats, which are the definitive hosts, shed infectious oocysts in their feces contaminating food and water sources. Infection is initiated by ingestion of either tissue cysts containing the bradyzoite life-cycle stage or oocysts (Dubey, 1998). Upon stage conversion into tachyzoites and invasion of a host cell, Toxoplasma forms a parasitophorous vacuole (PV) that is surrounded by the PV membrane (PVM) (Black and Boothroyd, 2000). During invasion, Toxoplasma secretes effector proteins from rhoptries (ROPs), which mediate invasion, inhibition of host restriction factors, and modulation of host signaling pathways (Dubremetz, 2007; Boothroyd and Dubremetz, 2008; Hakimi et al., 2017). Once inside the PV, proteins from the dense granule secretory organelles (GRAs) are secreted onto, and beyond the PVM into the host cell cytoplasm (Hakimi and Bougdour, 2015; Hakimi et al., 2017). Three putative translocon proteins: Myc-regulation 1 (MYR1) along with MYR2 and MYR3 determine transport of GRA16 and GRA24 across the PVM into the host cell cytoplasm after which they traffic to the host cell nucleus (Franco et al., 2016; Marino et al., 2018). In addition to these putative translocon proteins, an aspartyl protease, ASP5 cleaves many secreted GRA proteins at a characteristic RRLxx motif also known as the Toxoplasma export element (TEXEL) motif which is important for their localization and function (Coffey et al., 2015; Hammoudi et al., 2015). Most of these effectors that have been characterized are from the non-orally infectious tachyzoite stage. It is unclear if bradyzoites within tissue cysts, akin to tachyzoites within the PV, can secrete GRAs beyond the PVM as the cyst wall is built on the inside of the PVM (Jeffers et al., 2018) and presents a potential barrier for GRA secretion into the host cell.

GRA16, GRA24, GRA28 and IST (T. gondii inhibitor of STAT1 transcriptional activity) are secreted by tachyzoites beyond the PVM and traffic to the host nucleus (Bougdour et al., 2013; Braun et al., 2013; Gay et al., 2016; Nadipuram et al., 2016; Olias et al., 2016) where they modulate host signaling pathways important for parasite fitness. In this brief report we use the tetracycline inducible system to induce the expression of epitope tagged GRA16 and GRA24 after in vitro stage conversion. We observed that anhydrotetracycline (ATc) induced GRA16-HA and GRA24-HA are not secreted beyond the PVM and are not localized to the host cell nucleus. Instead, they accumulate within the in vitro tissue cysts.

Materials and Methods

Host Cells and Parasite Strain

Human foreskin fibroblasts (HFFs) were used as host cells and were cultured under standard conditions using Dulbecco Modified Eagle Medium (DMEM) with 10% fetal bovine serum (FBS) (Rosowski et al., 2011). We chose GT1 parasites expressing tetracycline repressor (Tet-R) (Etheridge et al., 2014), a type I strain that is capable of forming cysts during in vitro stage conversion (Lindsay et al., 1991; Fux et al., 2007) induced by pH 8-8.2+low CO2 (Skariah et al., 2010).

Plasmid Construction

Using Gibson assembly (Gibson et al., 2009), we constructed Tet-On plasmids with a phleomycin resistance cassette to express GRA16-HA and GRA24-HA. The pTeton vector backbone was amplified with the following primers which were used to construct both the pTetONGRA16-HA SRS22A3′UTR as well as the pTetONGRA24-HA SRS22A3UTR constructs:

vector TetON for-GCATCCACTAGTGCTCTTCAAGGTTTTACATC
CGTTGCCT

Vector TetON rev-AATTGCGCCATTTTGACGGTGACGAAGCC
ACCTGAGGAAGAC

The following primers were used to amplify the pieces for pTetONGRA16-HA SRS22A3′UTR Gibson assembly:

Vector GRA16 for-ACCGTCAAAATGGCGCAATTATGTATCGAAACCA
CTCAGGGATAC

SRS22UTRGRA16 rev-AATGACAGGTTCAAGCATAATCG
GGAACGTCGTATG

GRA16HA SRS22A for-TTATGCTTGAACCTGTCATTTAC
CTCCAGTAAACATG

SRS22Avector rev-TGAAGAGCACTAGTGGATGCGTTCT
AGTGCTGTACGGAAAAGCAAC

The following primers were used to amplify the pieces for pTetONGRA24-HA SRS22A3′UTR Gibson assembly:

vectorGRA24 for –ACCGTCAAAATGGCGCAATTATGCTC
CAGATGGCACGATATACCG

SRS22AUTRGRA24HA rev-AATGACAGGTTTAAGCATAA
TCGGGAACGTCGTATG

GRA24HASRS22A For-TTATGCTTAAACCTGTCATTTA
CCTCCAGTAAACATG.

Parasite Transfection and Selection

The pTetOn vectors containing GRA16-HA and GRA24-HA were linearized using the AseI restriction enzyme. The linearized plasmids (50 μg) were electroporated into 5 × 107 GT1tetR parasites using the protocol described in (Gold et al., 2015). After lysis of parasites from host cells, they were selected twice with 50 μg/ml phleomycin (Ble) and maintained in 5 μg/ml Ble (Krishnamurthy et al., 2016) after which they were cloned by limiting dilution.

Indirect Immunofluorescence With Tachyzoites

Coverslips with a monolayer of HFFs were infected in the presence or absence of 2 μM ATc with GT1-TetR parasites or single clones of parasites expressing GRA16-HA and GRA24-HA under the RPS13 promoter downstream of a Tet-O7 operator. The coverslips were fixed 16 h post infection with 3% formaldehyde and processed for IFA using rabbit anti-HA primary (Roche) antibody followed by goat anti-rabbit Alexa-555 secondary antibody and Hoechst (Invitrogen).

In Vitro Stage Differentiation and IFA With Tissue Cysts

HFFs were infected with a single clone of GT1-tetR parasites that expressed GRA16-HA only in the presence of ATc. The media was switched from DMEM with 10% FBS to tricine-buffered RPMI media with pH 8.0 and put in an incubator with low CO2 after 24 h of infection (MOI = 0.1) to induce tachyzoite to bradyzoite stage conversion. After 5 days, 2 μM ATc was added and 2 days later the coverslips were fixed with 100% cold methanol (also eliminates YFP signal from TetR) and processed for IFA. The cyst wall was stained with DBA-FITC (Boothroyd et al., 1997) along with HA and Hoechst as described above.

Results

To test if GRAs are secreted beyond the tissue cyst wall membrane, we utilized the Tet-inducible system (Etheridge et al., 2014) to express an HA-tagged copy of GRA16 or GRA24 under the Tet operator (Tet-O) in parasites expressing Tet-R. We could not just use GRA16-HA or GRA24-HA expressed from the endogenous promoter because if we saw these proteins in the host nucleus we would not know if they were secreted beyond the PVM before the cyst wall was made (as tachyzoites) or after the cyst wall was made (as bradyzoites). In the absence of anhydrotetracycline (ATc), the Tet-R binds to Tet-O and represses the transcription of either GRA16-HA or GRA24-HA under the RPS13 promoter (Etheridge et al., 2014; Wang et al., 2016). ATc binds TetR and relieves repression of transcription which allows for the expression of HA-tagged GRA16 or GRA24. Since ATc is smaller than the size-exclusion limit of the cyst wall (Lemgruber et al., 2011), we decided to use this system to answer our question.

To check if our constructs were able to stably express functional GRA16 and GRA24, we first transfected them into the RH parasite strain and observed nuclear localization of these proteins (data not shown). After transfection of the GT1 Tet-R expressing strain with the Tet-inducible GRA16-HA or GRA24-HA construct and subsequent selection with phleomycin for stable integration, we show by IFA that in tachyzoites GRA16-HA (Figures 1A,B) and GRA24-HA (Figures 1C,D) were only expressed in the presence of ATc.

FIGURE 1
www.frontiersin.org

Figure 1. GT1- TetR parasites express GRA16-HA and GRA24-HA only in the presence of ATc. A monolayer of HFFs were infected with single clones of GT1 Tet-R parasites, which contained either GRA16-HA or GRA24-HA cloned in front of a TetOn promoter, in the presence or absence of ATc. Cover slips were fixed 16 h post infection and processed for IFA as described. Tet-R is YFP tagged and GT1 Tet-R parasites do not express any proteins that are HA-epitope tagged (first panel). In the absence of ATc, Tet-R represses the expression of GRA16-HA (A first panel) and GRA24-HA (C first panel). Repression by Tet-R is relieved only in the presence of 2 μM ATc (second panel) allowing for the proper localization of GRA16-HA (A) and GRA24-HA (B) to the parasite PVM and host cell nucleus. Images are scaled to 10 μm. Quantification of GRA16-HA (C) and GRA24-HA (D) secreted into the host cell nucleus only in presence of ATc was done using ImageJ. Error bars indicate mean with SD and significance was determined by performing Student's t-test from 3 biological replicates using Graph Pad Prism7.0 (****P < 0.0001).

A single parasite clone that expressed GRA16-HA or GRA24-HA only in the presence of ATc was chosen for induction of stage differentiation in vitro in human foreskin fibroblast (HFFs). Five days post-switching, 2 μM of ATc was added to the cultures to induce the expression of GRA16-HA and GRA24-HA since we observed that at least 50% of the parasites had converted to cysts by staining the cyst wall with DBA-lectin (Boothroyd et al., 1997) (data not shown). The parasites were fixed 48 h following addition of ATc to allow for sufficient expression of GRA16-HA and GRA24-HA. We performed an indirect immunofluorescence assay (IFA) to determine the localization of GRA16 and GRA24 using anti-HA antibody as well as DBA-lectin to detect the cyst wall. We show that in host cells containing tissue cysts, GRA16-HA and GRA24-HA were not detected in the host cell nucleus or beyond the tissue cyst wall membrane and that instead they accumulated underneath the cyst wall. Almost 100% of vacuoles we observed were DBA positive. We decided to observe HFFs only infected with one parasite and therefore containing only one cyst as differences in the timing of conversion could affect the localization of GRA16 and GRA24. Out of 189 (80 for GRA16-HA and 109 for GRA24-HA from three biological replicates) images of singly infected host cells containing DBA positive cysts, both GRA16 and GRA24 were expressed exclusively beneath the cyst wall only in the presence of ATc (Figures 2A,B). We observed GRA16 and GRA24 localized to the host cell nucleus only in multiple infected cells containing tachyzoites, along with in vitro cysts (Supplemental Figure 1). Thus, our results show that GRA16 and GRA24 are not secreted beyond the tissue cyst membrane into the host cell.

FIGURE 2
www.frontiersin.org

Figure 2. In vitro DBA positive cysts do not secrete GRA16-HA and GRA24-HA beyond the cyst wall membrane. Stage differentiation was induced using single clones of parasites, which contained either GRA16-HA or GRA24-HA cloned in front of a TetOn promoter, 16 h post infection of coverslips containing HFFs. ATc was added to the monolayer containing cysts 5 days after inducing stage differentiation. Coverslips were processed for IFA with DBA-FITC to stain the cyst wall and anti-HA antibody to track the localization of GRAs16 and 24. In the absence of ATc, GRA16-HA (A first panel) and GRA24-HA (A first panel) were not detected in parasites. GRA16-HA (A second panel) and GRA24-HA (B second panel, inset) accumulated beneath the cyst wall only in the presence of ATc. Images are scaled to 10 μm. Fluorescence intensity was measured to quantify the localization of GRA16-HA and GRA24-HA in the nucleus of infected cells, uninfected cells as well as the tissue cysts in the presence and absence of ATc (C,D). Signal intensity was the highest and above background (uninfected cells) only for cysts in the presence of ATc. Error bars indicate mean with SD and significance was determined using Student's t-test from 3 biological replicates (**P < 0.05).

Discussion

We show here that GT1 parasites are able to form DBA lectin positive in vitro cysts. We also show for the first time that ATc is able to cross the cyst wall in vitro. Even though bradyzoites within tissue cysts are not as metabolically active compared to tachyzoites, it is becoming clear that they are also not in a dormant state (Sinai et al., 2016). However, we observed that bradyzoites do not secrete GRA16 and GRA24 beyond the in vitro cyst wall membrane. These proteins accumulated within the cyst wall suggesting that their role in the host cell nucleus is not required at this stage. In preparing for the chronic phase of their life cycle, bradyzoites lose connectivity between themselves through the intravacuolar network (IVN) and undergo asynchronous division (Frénal et al., 2017). Our data indicates that the bradyzoites within cysts also lose connectivity to host cells by not secreting GRAs, which usually modulate host signaling pathways in tachyzoites, beyond the PVM. Possibly bradyzoites require these proteins during natural oral infections after excystation from tissue cysts to establish infection in gut epithelial cells of the host. Not secreting parasite proteins beyond the cyst wall might help Toxoplasma to remain invisible and undetected by the host immune response during the chronic phase of infection. This hypothesis is in conjunction with published literature wherein proteins from dense granules (Ferguson, 2004; Lemgruber et al., 2011) and rhoptries (Schwarz et al., 2005) were shown to be secreted in bradyzoites but never beyond the tissue cyst wall. Another possibility may be that the translocon proteins MYR1/2/3 or ASP5 are not sufficiently expressed at this stage to effectively mediate transport of secreted GRAs beyond the cyst wall membrane. Even though all the MYRs and ASP5 are expressed in tachyzoites, sporozoites and bradyzoites, their expression is significantly lower in bradyzoites (Marino et al., 2018). However, even if MYR1-3 and ASP5 are expressed, our data indicate that the cyst wall seems to act as a barrier as ATc- induced GRA16 and GRA24 accumulated beneath the wall (Figure 2).

Author Contributions

SK generated all the data. SK and JS wrote and edited the manuscript.

Funding

This research was funded by NIH-5R01AI080621-10.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

We thank all the members of the Saeij lab for their feedback on this manuscript. We also thank Dr. Ronald D. Etheridge for proving us with GT1-TetR parasites.

Supplementary Material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2018.00366/full#supplementary-material

Supplemental Figure 1. Localization of GRA16-HA and GRA24-HA to the host cell nucleus was observed only in multiple infected host cells containing parasites in different stages of in vitro stage conversion. Parasites expressing GRA16-HA (A) or GRA24-HA (B) localized the respective epitope tagged GRAs in the parasites as well as in the host cell nucleus. Non-uniform DBA staining suggests that the parasites were in different stages of conversion into tissue cysts. Images are scaled to 10 μm.

Abbreviations

Tet-on, tetracycline inducible system; TetR, tetracycline repressor protein; ATc, anhydrotetracycline; HA, hemagglutinin epitope tag; YFP, yellow fluorescent protein; Ble, phleomycin; HFF, human foreskin fibroblast; DBA lectin, dolichos biflorus agglutinin; IFA, indirect immunofluorescence; GRA, dense granule proteins; ROP, rhoptry proteins; IST, T. gondii inhibitor of STAT1 transcriptional activity; PV, parasitophorous vacuole; PVM, PV membrane.

References

Black, M. W., and Boothroyd, J. C. (2000). Lytic cycle of Toxoplasma gondii. Microbiol. Mol. Biol. Rev. 64, 607–623. doi: 10.1128/MMBR.64.3.607-623.2000

PubMed Abstract | CrossRef Full Text | Google Scholar

Boothroyd, J. C., Black, M., Bonnefoy, S., Hehl, A., Knoll, L. N., Manger, I. D., et al. (1997). Genetic and biochemical analysis of development in Toxoplasma gondii. Phil.Trans. R. Soc. Lond. B 353, 1347–1354. doi: 10.1098/rstb.1997.0119

CrossRef Full Text | Google Scholar

Boothroyd, J. C., and Dubremetz, J. F. (2008). Kiss and spit: the dual roles of Toxoplasma rhoptries. Nat. Rev. Microbiol. 6, 79–88. doi: 10.1038/nrmicro1800

PubMed Abstract | CrossRef Full Text | Google Scholar

Bougdour, A., Durandau, E., Brenier-Pinchart, M. P., Ortet, P., Barakat, M., Kieffer, S., et al. (2013). Host cell subversion by Toxoplasma GRA16, an exported dense granule protein that targets the host cell nucleus and alters gene expression. Cell Host Microbe 13, 489–500. doi: 10.1016/j.chom.2013.03.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Braun, L., Brenier-Pinchart, M. P., Yogavel, M., Curt-Varesano, A., Curt-Bertini, R. L., Hussain, T., et al. (2013). A toxoplasma dense granule protein, GRA24, modulates the early immune response to infection by promoting a direct and sustained host p38 MAPK activation. J. Exp. Med. 210, 2071–2086. doi: 10.1084/jem.20130103

PubMed Abstract | CrossRef Full Text | Google Scholar

Coffey, M. J., Sleebs, B. E., Uboldi, A. D., Garnham, A., Franco, M., Marino, N. D., et al. (2015). An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell. Elife 4:e10809. doi: 10.7554/eLife.10809

PubMed Abstract | CrossRef Full Text | Google Scholar

Dubey, J. P. (1998). Advances in the life cycle of Toxoplasma gondii. Int. J. Parasitol. 28, 1019–1024. doi: 10.1016/S0020-7519(98)00023-X

PubMed Abstract | CrossRef Full Text | Google Scholar

Dubremetz, J. F. (2007). Rhoptries are major players in Toxoplasma gondii invasion and host cell interaction. Cell. Microbiol. 9, 841–848. doi: 10.1111/j.1462-5822.2007.00909.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Etheridge, R. D., Alaganan, A., Tang, K., Lou, H. J., Turk, B. E., and Sibley, L. D. (2014). The toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice. Cell Host Microbe 15, 537–550. doi: 10.1016/j.chom.2014.04.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Ferguson, D. J. (2004). Use of molecular and ultrastructural markers to evaluate stage conversion of Toxoplasma gondii in both the intermediate and definitive host. Int. J. Parasitol. 34, 347–360. doi: 10.1016/j.ijpara.2003.11.024

PubMed Abstract | CrossRef Full Text | Google Scholar

Franco, M., Panas, M. W., Marino, N. D., Lee, M. C., Buchholz, K. R., Kelly, F. D., et al. (2016). A novel secreted protein, MYR1, is central to toxoplasma's manipulation of host cells. MBio 7:e02231–e02215. doi: 10.1128/mBio.02231-15

PubMed Abstract | CrossRef Full Text | Google Scholar

Frénal, K., Jacot, D., Hammoudi, P.-M., Graindorge, A., Maco, B., and Soldati-Favre, D. (2017). Myosin-dependent cell-cell communication controls synchronicity of division in acute and chronic stages of Toxoplasma gondii. Nat. Commun. 8:15710. doi: 10.1038/ncomms15710

PubMed Abstract | CrossRef Full Text | Google Scholar

Fux, B., Nawas, J., Khan, A., Gill, D. B., Su, C., and Sibley, L. D. (2007). Toxoplasma gondii strains defective in oral transmission are also defective in developmental stage differentiation. Infect. Immun. 75, 2580–2590. doi: 10.1128/IAI.00085-07

PubMed Abstract | CrossRef Full Text | Google Scholar

Gay, G., Braun, L., Brenier-Pinchart, M. P., Vollaire, J., Josserand, V., Bertini, R. L., et al. (2016). Toxoplasma gondii TgIST co-opts host chromatin repressors dampening STAT1-dependent gene regulation and IFN-gamma-mediated host defenses. J. Exp. Med. 213, 1779–1798. doi: 10.1084/jem.20160340

PubMed Abstract | CrossRef Full Text | Google Scholar

Gibson, D. G., Young, L., Chuang, R. Y., Venter, J. C., Hutchison, C. A. III., and Smith, H. O. (2009). Enzymatic assembly of DNA molecules up to several hundred kilobases. Nat. Methods 6, 343–345. doi: 10.1038/nmeth.1318

PubMed Abstract | CrossRef Full Text | Google Scholar

Gold, D. A., Kaplan, A. D., Lis, A., Bett, G. C., Rosowski, E. E., Cirelli, K. M., et al. (2015). The toxoplasma dense granule proteins GRA17 and GRA23 mediate the movement of small molecules between the host and the parasitophorous vacuole. Cell Host Microbe 17, 642–652. doi: 10.1016/j.chom.2015.04.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Hakimi, M.-A., Olias, P., and Sibley, L. D. (2017). Toxoplasma effectors targeting host signaling and transcription. Clin. Microbiol. Rev. 30, 615–645. doi: 10.1128/CMR.00005-17

PubMed Abstract | CrossRef Full Text | Google Scholar

Hakimi, M. A., and Bougdour, A. (2015). Toxoplasma's ways of manipulating the host transcriptome via secreted effectors. Curr. Opin. Microbiol. 26, 24–31. doi: 10.1016/j.mib.2015.04.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Hammoudi, P. M., Jacot, D., Mueller, C., Di Cristina, M., Dogga, S. K., Marq, J. B., et al. (2015). Fundamental roles of the golgi-associated toxoplasma aspartyl protease, ASP5, at the host-parasite interface. PLoS Pathog. 11:e1005211. doi: 10.1371/journal.ppat.1005211

PubMed Abstract | CrossRef Full Text | Google Scholar

Jeffers, V., Tampaki, Z., Kim, K., and Sullivan, W. J. (2018). A latent ability to persist: differentiation in Toxoplasma gondii. Cell. Mol. Life Sci. 75, 2355–2373. doi: 10.1007/s00018-018-2808-x

PubMed Abstract | CrossRef Full Text | Google Scholar

Jones, J. L., and Dubey, J. P. (2012). Foodborne toxoplasmosis. Clin. Infect. Dis. 55, 845–851. doi: 10.1093/cid/cis508

PubMed Abstract | CrossRef Full Text | Google Scholar

Kim, K., and Weiss, L. M. (2004). Toxoplasma gondii: the model Apicomplexan. Int. J. Parasitol. 34, 423–432. doi: 10.1016/j.ijpara.2003.12.009

PubMed Abstract | CrossRef Full Text | Google Scholar

Krishnamurthy, S., Deng, B., Del Rio, R., Buchholz, K. R., Treeck, M., Urban, S., et al. (2016). Not a simple tether: binding of Toxoplasma gondii AMA1 to RON2 during Invasion Protects AMA1 from rhomboid-mediated cleavage and leads to dephosphorylation of its cytosolic tail. MBio 7:e00754-16. doi: 10.1128/mBio.00754-16

PubMed Abstract | CrossRef Full Text | Google Scholar

Lemgruber, L., Lupetti, P., Martins-Duarte, E. S., De Souza, W., and Vommaro, R. C. (2011). The organization of the wall filaments and characterization of the matrix structures of Toxoplasma gondii cyst form. Cell. Microbiol. 13, 1920–1932. doi: 10.1111/j.1462-5822.2011.01681.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Lindsay, D. S., Dubey, J. P., Blagburn, B. L., and Toivio-Kinnucan, M. (1991). Examination of tissue cyst formation by Toxoplasma gondii in cell cultures usingbradyzoites, tachyzoites, and sporozoites. J. Parasitol. 77, 126–132. doi: 10.2307/3282569

PubMed Abstract | CrossRef Full Text | Google Scholar

Marino, N. D., Panas, M. W., Franco, M., Theisen, T. C., Naor, A., Rastogi, S., et al. (2018). Identification of a novel protein complex essential for effector translocation across the parasitophorous vacuole membrane of Toxoplasma gondii. PLoS Pathog. 14:e1006828. doi: 10.1371/journal.ppat.1006828

PubMed Abstract | CrossRef Full Text | Google Scholar

Montoya, J. G., and Liesenfeld, O. (2004). Toxoplasmosis. Lancet 363, 1965–1976. doi: 10.1016/S0140-6736(04)16412-X

PubMed Abstract | CrossRef Full Text | Google Scholar

Nadipuram, S. M., Kim, E. W., Vashisht, A. A., Lin, A. H., Bell, H. N., Coppens, I., et al. (2016). In vivo biotinylation of the toxoplasma parasitophorous vacuole reveals novel dense granule proteins important for parasite growth and pathogenesis. MBio 7:e00808-16. doi: 10.1128/mBio.00808-16

PubMed Abstract | CrossRef Full Text | Google Scholar

Olias, P., Etheridge, R. D., Zhang, Y., Holtzman, M. J., and Sibley, L. D. (2016). Toxoplasma effector recruits the Mi-2/NuRD complex to repress STAT1 transcription and block IFN-gamma-dependent gene expression. Cell Host Microbe 20, 72–82. doi: 10.1016/j.chom.2016.06.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Rosowski, E. E., Lu, D., Julien, L., Rodda, L., Gaiser, R. A., Jensen, K. D., et al. (2011). Strain-specific activation of the NF-kappaB pathway by GRA15, a novel Toxoplasma gondii dense granule protein. J. Exp. Med. 208, 195–212. doi: 10.1084/jem.20100717

PubMed Abstract | CrossRef Full Text | Google Scholar

Schwarz, J. A., Fouts, A. E., Cummings, C. A., Ferguson, D. J., and Boothroyd, J. C. (2005). A novel rhoptry protein in Toxoplasma gondii bradyzoites and merozoites. Mol. Biochem. Parasitol. 144, 159–166. doi: 10.1016/j.molbiopara.2005.08.011

PubMed Abstract | CrossRef Full Text | Google Scholar

Sinai, A. P., Watts, E. A., Dhara, A., Murphy, R. D., Gentry, M. S., and Patwardhan, A. (2016). Reexamining chronic Toxoplasma gondii infection: surprising activity for a “Dormant” parasite. Curr. Clin. Microbiol. Rep. 3, 175–185. doi: 10.1007/s40588-016-0045-3

PubMed Abstract | CrossRef Full Text | Google Scholar

Skariah, S., McIntyre, M. K., and Mordue, D. G. (2010). Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion. Parasitol. Res. 107, 253–260. doi: 10.1007/s00436-010-1899-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Wang, J. L., Huang, S. Y., Behnke, M. S., Chen, K., Shen, B., and Zhu, X. Q. (2016). The past, present, and future of genetic manipulation in Toxoplasma gondii. Trends Parasitol. 32, 542–553. doi: 10.1016/j.pt.2016.04.013

PubMed Abstract | CrossRef Full Text | Google Scholar

Weiss, L. M., and Dubey, J. P. (2009). Toxoplasmosis: a history of clinical observations. Int. J. Parasitol. 39, 895–901. doi: 10.1016/j.ijpara.2009.02.004

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: Toxoplasma gondii, secreted effectors, tissue cyst wall, tetracycline inducible expression, GRA16, GRA24

Citation: Krishnamurthy S and Saeij JPJ (2018) Toxoplasma Does Not Secrete the GRA16 and GRA24 Effectors Beyond the Parasitophorous Vacuole Membrane of Tissue Cysts. Front. Cell. Infect. Microbiol. 8:366. doi: 10.3389/fcimb.2018.00366

Received: 06 July 2018; Accepted: 01 October 2018;
Published: 18 October 2018.

Edited by:

Mohamed Ali Hakimi, Institut National de la Santé et de la Recherche Médicale (INSERM), France

Reviewed by:

Markus Meissner, Ludwig-Maximilians-Universität München, Germany
Renato Augusto DaMatta, State University of Norte Fluminense, Brazil

Copyright © 2018 Krishnamurthy and Saeij. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Jeroen P. J. Saeij, jsaeij@ucdavis.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.